These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38554698)
1. Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: A systematic review and meta-analysis. Cohen-Laroque J; Grangier I; Perez N; Kirschner M; Kaiser S; Sabé M Schizophr Res; 2024 May; 267():182-190. PubMed ID: 38554698 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of risk factors for methamphetamine-associated psychosis. Arunogiri S; Foulds JA; McKetin R; Lubman DI Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289 [TBL] [Abstract][Full Text] [Related]
3. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis. Yang M; Yang C; Liu T; London ED Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149 [No Abstract] [Full Text] [Related]
4. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study. Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621 [TBL] [Abstract][Full Text] [Related]
5. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine. McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188 [No Abstract] [Full Text] [Related]
7. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence. Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828 [TBL] [Abstract][Full Text] [Related]
8. Is there a discrete negative symptom syndrome in people who use methamphetamine? Voce A; Burns R; Castle D; Calabria B; McKetin R Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605 [TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity? Reisner AD; Piel JL J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213 [No Abstract] [Full Text] [Related]
10. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Grelotti DJ; Kanayama G; Pope HG Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123 [TBL] [Abstract][Full Text] [Related]
11. Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. Kishi T; Fukuo Y; Okochi T; Kitajima T; Kawashima K; Naitoh H; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N Drug Alcohol Depend; 2011 Jan; 113(1):1-7. PubMed ID: 20705401 [TBL] [Abstract][Full Text] [Related]
12. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention. Zhu L; Ni T; Guan F Am J Psychiatry; 2024 Feb; 181(2):168. PubMed ID: 38298079 [No Abstract] [Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study. Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749 [TBL] [Abstract][Full Text] [Related]
15. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up. Javadian S; Shabani A; Shariat SV Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276 [TBL] [Abstract][Full Text] [Related]
16. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Kishi T; Tsunoka T; Ikeda M; Kitajima T; Kawashima K; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N Neuropharmacology; 2010 Feb; 58(2):452-6. PubMed ID: 19747927 [TBL] [Abstract][Full Text] [Related]
17. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471 [TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al. Rognli EB; Høye A; Bramness JG Am J Psychiatry; 2024 Feb; 181(2):168-169. PubMed ID: 38298080 [No Abstract] [Full Text] [Related]
20. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Yui K; Ikemoto S; Ishiguro T; Goto K Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]